Press release
Sales of Ocular Drug Delivery Technology Market to Grow 1.4x by 2025
It is anticipated that glaucoma cases will surpass 100 million by 2040, while macular degeneration shall reach nearly 200 million by 2020-end. These increasing cases are poised to heighten prospects for ocular drug delivery market in the forecast period (2020-2025).For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4802
Immense research and development is occurring in the ocular drug delivery market. Shortages in bioavailability of such drugs is a key growth driver. Studies have shown that micellar formulations and derivative active pharmaceutical ingredients have immense scope for development. Based on these trends, the global ocular drug delivery technology market is poised to register positive growth. The market is anticipated to expand 1.4x by 2025-end.
Key Takeaways of Global Ocular Drug Delivery Technology Market Study:
• By technology, topical drug delivery is set to dominate the market, capturing nearly half of the market share. Affordability and introduction of emulsion and suspension forms are attributed as key growth drivers. The topical drugs segment is close behind, expanding 1.4x. Long-term effectiveness and precise drug delivery are important growth drivers.
• By formulation type, solutions are anticipated to capture the majority share, accounting for more than three-fifths of the global ocular drug delivery technology market. High production volume, high-patient compliance and cost effectiveness are important growth levers.
For critical insights on this market, request for methodology here -https://www.factmr.com/connectus/sample?flag=RM&rep_id=4802
• By disease type, macular degeneration is set to dominate the global ocular drug delivery technology market. This is followed by diabetic retinopathy. Each segment is poised to account for more than one-fifth of the market share. Rising prevalence of the diseases is the main driver behind the growth of these segments.
• By end-user, hospitals are poised to account for a major chunk of the market. This is attributed to availability of trained and qualified personnel and well-equipped healthcare facilities. Moreover, technology integration in hospital systems is also set to brighten growth of the segment.
Global Ocular Drug Delivery Technology Market Segmentation
Fact.MR has studied the global ocular drug delivery technology market with detailed segmentation on the basis of technology type, formulation type, disease type, end-user and region.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4802
Technology Type
• Topical
• Ocular Inserts:
• Non-erodible
• Erodible
• Iontophoresis
• Intraocular Implants:
• Biodegradable
• Non-biodegradable
• In-Situ Gel & Punctal Plugs
• Others
Formulation Type
• Solution
• Suspension
• Emulsion
• Liposomes & Nanoparticles
• Ointment
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/07/29/1892912/0/en/Dental-Anesthetics-Sales-Will-Witness-a-Promising-Leap-as-Dental-Tourism-Continues-to-Proliferate-Says-Fact-MR.html
Key Manufactures Concentrate on Wholesale Shift to New Formulations:
The global ocular drug delivery market is consolidated, consisting of a limited number of market players. They are: Ocular Therapeutix, Inc., Alimera Sciences, Allergan plc, Valeant Pharmaceuticals International (Bausch Health Company), Inc., and Santen Pharmaceutical Co., Ltd. Developing new drug formulae drives market growth of leading players.
Valeant Pharmaceuticals (Bausch & Lomb, Inc.) is a leader in the ocular drug delivery market. It specializes in a number of ophthalmic drugs for a number of conditions. These include glaucoma, conjunctivitis, uveitis and cataracts. Its brands are Bepreve, Istalol, Besivance, Alrex and Zylet. In 2017, the company announced the introduction of Biotrue ONEday, daily disposable contact lenses for Astigmatism. Another market leader, Santen pharmaceuticals, specializes in corneal and retinal diseases such as Dry Eyes, Uveitis, AMD and Diabetic Retinopathy, and Glaucoma. Its products include Tafluprost, Ciclosporin, Sepetaprost and Carotuximab.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1570/global-ocular-drug-delivery-technology-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sales of Ocular Drug Delivery Technology Market to Grow 1.4x by 2025 here
News-ID: 2329790 • Views: …
More Releases from Fact.MR
Medical Membranes Market Growing at a 7% CAGR, North America Dominates with Sign …
The global medical camera market is experiencing significant growth, driven by advancements in imaging technologies and an increasing demand for minimally invasive procedures. Medical cameras are essential tools in various medical specialties, including endoscopy, ophthalmology, dermatology, and surgical microscopy. These devices provide high-resolution images that assist healthcare professionals in diagnosing and treating patients more effectively. The integration of features such as high-definition imaging, wireless connectivity, and artificial intelligence is further…
Medical Camera Market North America Holds Largest Market Share in 2025 | Olympus …
The global medical camera market is experiencing significant growth, driven by advancements in imaging technologies and an increasing demand for minimally invasive procedures. Medical cameras are essential tools in various medical specialties, including endoscopy, ophthalmology, dermatology, and surgical microscopy. These devices provide high-resolution images that assist healthcare professionals in diagnosing and treating patients more effectively. The integration of features such as high-definition imaging, wireless connectivity, and artificial intelligence is further…
e-paper Displays Market Valued at USD 4.5 billion in 2025 | E Ink Holdings, Perv …
The global e-paper displays market is experiencing significant growth, driven by increasing demand for energy-efficient and environmentally friendly display technologies. E-paper displays, also known as electronic paper displays (EPD), offer several advantages over traditional display technologies, including low power consumption, high readability in various lighting conditions, and the ability to retain images without continuous power. These characteristics make e-paper displays ideal for applications such as e-readers, electronic shelf labels, and…
Laser Diode Market is Estimated To Increase At A Stellar 13% CAGR Through 2028 | …
The global laser diode market is witnessing significant growth, driven by rising demand across industries such as telecommunications, healthcare, automotive, and industrial applications. Laser diodes, also referred to as semiconductor lasers, are compact, efficient devices capable of emitting coherent light, making them ideal for precise applications such as data transmission, medical treatments, and industrial manufacturing. Advances in laser diode technology have improved performance and reduced costs, making these devices accessible…
More Releases for Ocular
How the Ocular Pain Market Is Growing in 2025 | What's New Treatments Are Coming …
According to the IMARC Group, the ocular pain market is expected to exhibit a CAGR of 7.66% during 2025-2035. This can be attributed to the growing use of services in teleophthalmology, which facilitates remote consultations and enhances patient adherence.
Ocular pain is the discomfort or distress experienced within or around the eye. The ocular pain market is experiencing significant growth driven by multiple factors. Primarily, the increasing prevalence of conditions such…
Key Influencer in the Ocular Implants Market 2025: Growing Geriatric Population …
What market dynamics are playing a key role in accelerating the growth of the ocular implants market?
The growth of the ocular implants market is foreseen to be driven by the global increase in the geriatric population. The term 'geriatric population' is specifically used to refer to individuals aged 65 years or above. Ocular implants offer a solution to age-specific eye ailments prevalent among the elderly, such as cataracts, glaucoma, and…
Neuropathic Ocular Pain Market Is Booming Worldwide 2025-2032 | OKYO Pharma, Lim …
Latest Report, titled "Neuropathic Ocular Pain Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Neuropathic Ocular Pain market has been…
Neuropathic Ocular Pain Market Detailed In New Research Report 2024 |OKYO Pharma …
A recent report from Coherent Market Insight titled "Neuropathic Ocular Pain Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2031" presents a thorough examination of the industry landscape, offering insights into market analysis and trends. Alongside competitor and regional analysis, the report delves into contemporary advancements within the market.
Global Neuropathic Ocular Pain market is estimated to be valued at US$ 197.1 million in 2023 and is expected to…
Ocular Neuropathic Pain Market to witness Robust Expansion by 2031 - OKYO Pharma …
Ocular neuropathic pain (ONP) is chronic eye pain caused by nerve damage or dysfunction. It can result from various conditions, such as corneal nerve injury, ocular surgeries, infections, or systemic diseases like diabetes. Patients experience persistent, burning, or stabbing eye pain, often without visible signs of inflammation. Diagnosis involves detailed patient history, clinical examination, and sometimes specialized tests. Treatment focuses on managing pain and may include topical or systemic medications,…
Ocular Implant Market - Redefining Ophthalmic Solutions: Choose Ocular Implants …
Newark, New Castle, USA: The "Ocular Implant Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Ocular Implant Market: https://www.growthplusreports.com/report/ocular-implant-market/7864
This latest report researches the industry structure, sales, revenue,…
